Tech Company Financing Transactions

Nautilus Neurosciences Funding Round

Galen Partners participated in a funding round for Nautilus Neurosciences. This venture round was announced by the company on 4/13/2010.

Transaction Overview

Announced On
4/13/2010
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors

Galen Partners (David Azad)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
135 Routes 202/206
Bedminster, NJ 07921
USA
Email Address
Overview
Nautilus Neurosciences is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with relevant products and services that directly benefit those affected by neurological disorders.
Profile
Nautilus Neurosciences LinkedIn Company Profile
Social Media
Nautilus Neurosciences Company Twitter Account
Company News
Nautilus Neurosciences News
Facebook
Nautilus Neurosciences on Facebook
YouTube
Nautilus Neurosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
William Maichle
  William Maichle LinkedIn Profile  William Maichle Twitter Account  William Maichle News  William Maichle on Facebook
Chief Financial Officer
Neil Milano
  Neil Milano LinkedIn Profile  Neil Milano Twitter Account  Neil Milano News  Neil Milano on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/13/2010: XDN venture capital transaction
Next: 4/13/2010: MyLikes venture capital transaction

 

Share this article

 


About Database of VC Transactions

We report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary